Technological advances are driving rapid progress in disease areas such as oncology, immuno-oncology and neuroscience, revealing new treatment possibilities. Scientists are now able to interrogate cellular biology and cell-to-cell interactions in previously unachievable ways, gaining deeper insight, faster, and advancing the development of innovative strategies for targeting cancer.
Notable developments in live-cell assays and in vitro translational models have enabled real-time studies of cancer cells, using systems such as Incucyte®. Join the webinar to learn about the latest Incucyte® Live-Cell Analysis Systems technology.
Kimberly Wicklund, Ph.D.
Head of Product Management
Dan Appledorn, Ph.D.
Head of Product Development, Cell Imaging
Edward “Ted” Hinchcliffe, Ph.D.
I.J. Holton Professor
The Hormel Institute
University of Minnesota